494 related articles for article (PubMed ID: 12388665)
1. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
[TBL] [Abstract][Full Text] [Related]
2. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
[TBL] [Abstract][Full Text] [Related]
3. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
Giusti P; Ducić I; Puia G; Arban R; Walser A; Guidotti A; Costa E
J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
[TBL] [Abstract][Full Text] [Related]
4. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
Griebel G; Perrault G; Simiand J; Cohen C; Granger P; Decobert M; Françon D; Avenet P; Depoortere H; Tan S; Oblin A; Schoemaker H; Evanno Y; Sevrin M; George P; Scatton B
J Pharmacol Exp Ther; 2001 Aug; 298(2):753-68. PubMed ID: 11454940
[TBL] [Abstract][Full Text] [Related]
5. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
Jenck F; Moreau JL; Bonetti EP; Martin JR; Haefely WE
J Pharmacol Exp Ther; 1992 Sep; 262(3):1121-7. PubMed ID: 1356150
[TBL] [Abstract][Full Text] [Related]
6. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
[TBL] [Abstract][Full Text] [Related]
7. Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one].
Licata SC; Platt DM; Cook JM; Sarma PV; Griebel G; Rowlett JK
J Pharmacol Exp Ther; 2005 Jun; 313(3):1118-25. PubMed ID: 15687371
[TBL] [Abstract][Full Text] [Related]
8. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling.
Klodzinska A; Tatarczyńska E; Chojnacka-Wójcik E; Nowak G; Cosford ND; Pilc A
Neuropharmacology; 2004 Sep; 47(3):342-50. PubMed ID: 15275823
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
[TBL] [Abstract][Full Text] [Related]
11. Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators.
Dazzi L; Motzo C; Imperato A; Serra M; Gessa GL; Biggio G
J Pharmacol Exp Ther; 1995 Apr; 273(1):241-7. PubMed ID: 7714771
[TBL] [Abstract][Full Text] [Related]
12. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
Langen B; Egerland U; Bernöster K; Dost R; Unverferth K; Rundfeldt C
J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
14. Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality.
Jacobsen EJ; Stelzer LS; TenBrink RE; Belonga KL; Carter DB; Im HK; Im WB; Sethy VH; Tang AH; VonVoigtlander PF; Petke JD; Zhong WZ; Mickelson JW
J Med Chem; 1999 Apr; 42(7):1123-44. PubMed ID: 10197957
[TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
[TBL] [Abstract][Full Text] [Related]
16. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands.
Griebel G; Perrault G; Tan S; Schoemaker H; Sanger DJ
Behav Pharmacol; 1999 Sep; 10(5):483-95. PubMed ID: 10780255
[TBL] [Abstract][Full Text] [Related]
18. CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.
Bernard PS; Bennett DA; Pastor G; Yokoyama N; Liebman JM
J Pharmacol Exp Ther; 1985 Oct; 235(1):98-105. PubMed ID: 2995650
[TBL] [Abstract][Full Text] [Related]
19. GABA A receptor subtype selectivity underlying selective anxiolytic effect of baicalin.
Wang F; Xu Z; Ren L; Tsang SY; Xue H
Neuropharmacology; 2008 Dec; 55(7):1231-7. PubMed ID: 18723037
[TBL] [Abstract][Full Text] [Related]
20. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
